Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
events
2
×
health
startups
2
×
tc
ajay royan
battlefield
cancer
disease
disrupt sf 2017
frederic moll
johnson & johnson
medicine
techcrunch disrupt sf 2019
What
ajay
auris
available
billion
cancer
ceo
come
company
consequence
critical
day
despite
determining
disrupt
dozens
entrepreneurs
frederic
great
guesswork
hansen
having
household
important
include
intuitive
inventors
investor
j
late
lead
manufacturer
matters
medical
miscalculate
moll
moll’s
old
ourotech
path
prioritize
Language
Current search:
techcrunch.com
×
startups
×
biotech
×
events
×
@techcrunch.com
4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
@techcrunch.com
6 years ago
Ourotech is taking the guesswork out of cancer treatment